Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.3925
-0.0101 (-2.51%)
At close: Dec 1, 2025, 4:00 PM EST
0.3910
-0.0015 (-0.38%)
After-hours: Dec 1, 2025, 4:00 PM EST
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $1.7 million as of December 1, 2025. Its market cap has decreased by -81.66% in one year.
Market Cap
1.70M
Enterprise Value
-1.89M
1-Year Change
-81.66%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $1.70M, a decrease of -99.18%. That is a compound annual growth rate of -76.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 1.75M | -82.11% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |